RT–PCR analysis on RNA extracted from mouse xenografts with and without TRAIL treatment showed an upregulation of DR4 and DR5 only in DLD-1 and PAP60 both of which were sensitive to TRAIL in vivo and had a reduction in tumour size. This evidence concerns the gene TNFRSF10B and neoplasm.